Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's Apellis Pharmaceuticals, Inc. (APLS) position

Yes: as of Q1 2026, Jim Simons holds 936K shares of APLS worth $38M (0.1% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$38M
Shares held
936K
% of portfolio
0.1%
Est. average buy price (i)
$22.84
est. since Q4 2025
Quarter-end price
$40.23

Estimated trade prices

Average price in quarters with purchases
$36.93
Average prices in quarters with sales
  • Q4 2024: $30.07 (100K shares sold)
  • Q4 2022: $53.04 (158K shares sold)
  • Q2 2021: $51.60 (353K shares sold)

APLS price vs Simons's position

Dates
$10$50$10020222023202420252026Sold 353K shares (94.6%) · Q2 2021. Average closing price $51.60 · Price range $40.90–$64.90353KsharessoldNew position of 345K shares · Q3 2022. Average closing price $59.17 · Price range $44.76–$68.67345KsharespurchasedSold 158K shares (45.7%) · Q4 2022. Average closing price $53.04 · Price range $43.24–$61.04158KsharessoldNew position of 139K shares · Q2 2023. Average closing price $86.28 · Price range $76.68–$93.31139KsharespurchasedNew position of 372K shares · Q3 2024. Average closing price $37.03 · Price range $28.84–$41.15372KsharespurchasedSold 100K shares (27.0%) · Q4 2024. Average closing price $30.07 · Price range $26.18–$35.42100KsharessoldNew position of 11K shares · Q2 2025. Average closing price $18.51 · Price range $16.36–$23.0011KsharespurchasedAdded 712K shares (over 1,000%) · Q3 2025. Average closing price $23.32 · Price range $17.42–$28.65712KsharespurchasedAdded 303K shares (47.8%) · Q1 2026. Average closing price $21.55 · Price range $16.97–$40.23303Ksharespurchased
Average closing price · filing quarter
$21.55
Price range · filing quarter
$16.97 – $40.23

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +303K +$6.5M +47.8% 936K May 14, 2026
Q4 2025 First covered 633K Feb 12, 2026
Q3 2025 Added +712K +$17M +6,478.9% 723K Nov 13, 2025
Q2 2025 New +11K +$203K 11K Aug 13, 2025
Q4 2024 Reduced −100K −$3.0M −27.0% 272K Feb 13, 2025
Q3 2024 New +372K +$14M 372K Nov 13, 2024
Q2 2023 New +139K +$12M 139K Aug 11, 2023
Q4 2022 Reduced −158K −$8.4M −45.7% 187K Feb 13, 2023
Q3 2022 New +345K +$20M 345K Nov 14, 2022
Q2 2021 Reduced −353K −$18M −94.6% 20K Aug 13, 2021
Q1 2021 First covered 374K May 13, 2021
Data through Q1 2026 · filed May 14, 2026
11 grouped rows from 11 quarters

More Simons positions

Common questions

Does Jim Simons own APLS?

Yes. As of Q1 2026, Jim Simons disclosed 936K shares of APLS, worth $38M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy APLS?

Jim Simons held APLS since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell APLS?

The quarter-by-quarter table above shows each sale and reduction Jim Simons disclosed in APLS. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of APLS does Jim Simons own?

Jim Simons disclosed 936K shares of APLS as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for APLS?

Jim Simons began building the APLS position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.